Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 1, 2006 - Issue 2
Submit an article Journal homepage
21
Views
0
CrossRef citations to date
0
Altmetric
Review

Genetic and modifiable risk factors for age-related macular degeneration

Jie Jin Wang University of Sydney, Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute, Hawkesbury Road, Westmead, 2145 NSW, Australia. [email protected]
Pages 181-194 | Published online: 09 Jan 2014

References

  • Rahmani B, Tielsch JM, Katz J et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology103, 1721–1726 (1996).
  • Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest. Ophthalmol. Vis. Sci.36, 182–191 (1995).
  • Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch. Ophthalmol.116, 653–658 (1998).
  • Wang JJ, Foran S, Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin. Experiment Ophthalmol.28, 268–273 (2000).
  • Rodriguez J, Sanchez R, Munoz B et al. Causes of blindness and visual impairment in a population-based sample of US Hispanics. Ophthalmology109, 737–743 (2002).
  • VanNewkirk MR, Weih L, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology108, 960–967 (2001).
  • Fine SL. Age-related macular degeneration 1969–2004: a 35-year personal perspective. Am. J. Ophthalmol.139, 405–420 (2005).
  • Evans JR. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res.20, 227–253 (2001).
  • Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr. Opin. Ophthalmol.13, 171–175 (2002).
  • Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol.48, 257–293 (2003).
  • Klein R, Peto T, Bird A, VanNewkirk MR. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol.137, 486–95 (2004).
  • Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int. Ophthalmol. Clin.44, 17–39 (2004).
  • Espinosa-Heidmann DG, Suner I, Hernandez EP, Frazier WD, Csaky KG, Cousins SW. Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.43, 1567–1573 (2002).
  • Espinosa-Heidmann DG, Sall J, Hernandez EP, Cousins SW. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest. Ophthalmol. Vis. Sci.45, 260–266 (2004).
  • Tuo J, Bojanowski CM, Chan CC. Genetic factors of age-related macular degeneration. Prog. Retin. Eye Res.23, 229–249 (2004).
  • Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv. Ophthalmol.51, 316–363 (2006).
  • Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol.51, 137–152 (2006).
  • Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol.134, 411–431 (2002).
  • Smith W, Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust. NZ J. Ophthalmol.26, 203–206 (1998).
  • Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch. Ophthalmol.116, 1646–1651 (1998).
  • Klein BE, Klein R, Lee KE, Moore EL, Danforth L. Risk of incident age-related eye diseases in people with an affected sibling : The Beaver Dam Eye Study. Am. J. Epidemiol.154, 207–211 (2001).
  • Assink JJ, Klaver CC, Houwing-Duistermaat JJ et al. Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. Ophthalmology112, 482–487 (2005).
  • Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am. J. Ophthalmol.123, 199–206 (1997).
  • Keverline MR, Mah TS, Keverline PO, Gorin MB. A practice-based survey of familial age-related maculopathy. Ophthalmic Genet.19, 19–26 (1998).
  • Yoshida A, Yoshida M, Yoshida S, Shiose S, Hiroishi G, Ishibashi T. Familial cases with age-related macular degeneration. Jpn J. Ophthalmol.44, 290–295 (2000).
  • Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch. Ophthalmol.112, 932–937 (1994).
  • Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol. Scand.77, 422–425 (1999).
  • Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology109, 730–736 (2002).
  • Grizzard SW, Arnett D, Haag SL. Twin study of age-related macular degeneration. Ophthalmic Epidemiol.10, 315–322 (2003).
  • de Jong PT, Bergen AA, Klaver CC, van Duijn CM, Assink JM. Age-related maculopathy: its genetic basis. Eye15, 396–400 (2001).
  • Gorin MB, Breitner JC, de Jong PT et al. The genetics of age-related macular degeneration. Mol. Vis.5, 29 (1999).
  • Daiger SP. Was the Human Genome Project worth the effort? Science308, 362–364 (2005).
  • Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science308, 385–389 (2005).
  • Edwards AO, Ritter IR, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science308, 421–424 (2005).
  • Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science308, 419–421 (2005).
  • Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci USA102, 7227–7232 (2005).
  • Zareparsi S, Branham KE, Li M et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet.77, 149–153 (2005).
  • Conley YP, Thalamuthu A, Jakobsdottir J et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum. Mol. Genet.14, 1991–2002 (2005).
  • Souied EH, Leveziel N, Richard F et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol. Vis.11, 1135–1140 (2005).
  • Magnusson KP, Duan S, Sigurdsson H et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS. Med.3, e5 (2006).
  • Sepp T, Khan JC, Thurlby DA et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Ophthalmol. Vis. Sci.47, 536–540 (2006).
  • Despriet DD, Klaver CC, Witteman JC et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA296, 301–309 (2006).
  • Postel EA, Agarwal A, Caldwell J et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology113(9), 1504–1507 (2006).
  • Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet.77, 389–407 (2005).
  • Rivera A, Fisher SA, Fritsche LG et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet.14, 3227–3236 (2005).
  • Schmidt S, Hauser MA, Scott WK et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet.78, 852–864 (2006).
  • Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet.38, 458–462 (2006).
  • Fisher SA, Abecasis GR, Yashar BM et al. Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet.14, 2257–2264 (2005).
  • Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am. J. Hum. Genet.73, 780–790 (2003).
  • Majewski J, Schultz DW, Weleber RG et al. Age-related macular degeneration – a genome scan in extended families. Am. J. Hum. Genet.73, 540–550 (2003).
  • Weeks DE, Conley YP, Tsai HJ et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum. Genet.75, 174–189 (2004).
  • Iyengar SK, Song D, Klein BE et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am. J. Hum. Genet.74, 20–39 (2004).
  • Kenealy SJ, Schmidt S, Agarwal A et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol. Vis.10, 57–61 (2004).
  • Gorin MB. The coming of age for age-related macular degeneration genetics. Ophthalmic Genet.26, 57–59 (2005).
  • Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl Acad. Sci. USA102, 7053–7054 (2005).
  • Tuo J, Ning B, Bojanowski CM et al. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc. Natl Acad. Sci. USA103, 9256–9261 (2006).
  • Haines JL, Schnetz-Boutaud N, Schmidt S et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest. Ophthalmol. Vis. Sci.47, 329–335 (2006).
  • Souied EH, Benlian P, Amouyel P et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am. J. Ophthalmol.125, 353–359 (1998).
  • Klaver CC, Kliffen M, van Duijn CM et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet.63, 200–206 (1998).
  • Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica214, 289–291 (2000).
  • Schmidt S, Saunders AM, De La Paz MA et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol. Vis.6, 287–293 (2000).
  • Simonelli F, Margaglione M, Testa F et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res.33, 325–328 (2001).
  • Schultz DW, Klein ML, Humpert A et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch. Ophthalmol.121, 679–683 (2003).
  • Schmidt S, Klaver C, Saunders A et al. A pooled case–control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet.23, 209–223 (2002).
  • Zareparsi S, Reddick AC, Branham KE et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest. Ophthalmol. Vis. Sci.45, 1306–1310 (2004).
  • Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.45, 1311–1315 (2004).
  • Wong TY, Shankar A, Klein R et al. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Ophthalmology113, 255–259 (2006).
  • Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J. Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am. J. Epidemiol.164, 813–822 (2006).
  • Schmidt S, Haines JL, Postel EA et al. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol. Vis.11, 941–949 (2005).
  • Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered.61, 157–165 (2006).
  • Chaine G, Hullo A, Sahel J et al. Case–control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br. J. Ophthalmol.82, 996–1002 (1998).
  • Khan JC, Shahid H, Thurlby DA et al. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br. J. Ophthalmol.90, 29–32 (2006).
  • Sandberg MA, Gaudio AR, Miller S, Weiner A. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.35, 2734–2740 (1994).
  • Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology105, 1359–1363 (1998).
  • Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch. Ophthalmol.116, 506–513 (1998).
  • Wang JJ, Jakobsen K, Smith W, Mitchell P. Five-year incidence of age-related maculopathy in relation to iris, skin or hair colour, and skin sun sensitivity: the Blue Mountains Eye Study. Clin. Experiment Ophthalmol.31, 317–321 (2003).
  • Tomany SC, Klein R, Klein BE. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology110, 1526–1533 (2003).
  • Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case–control study. Ophthalmology104, 770–776 (1997).
  • Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch. Ophthalmol.114, 1193–1196 (1996).
  • Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch. Ophthalmol.114, 1518–1523 (1996).
  • McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch. Ophthalmol.119, 1455–1462 (2001).
  • Delcourt C, Diaz JL, Ponton Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch. Ophthalmol.116, 1031–1035 (1998).
  • Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA276, 1147–1151 (1996).
  • Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA276, 1141–1146 (1996).
  • Age-related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case–control study in the age-related eye disease study: age-related eye disease study report No. 3. Age-Related Eye Disease Study Research Group. Ophthalmology107, 2224–2232 (2000).
  • DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol.122, 575–580 (2004).
  • Khan JC, Thurlby DA, Shahid H et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br. J. Ophthalmol.90, 75–80 (2006).
  • Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye19, 935–944 (2005).
  • Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am. J. Ophthalmol.141, 79–87 (2006).
  • Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch. Ophthalmol.124, 995–1001 (2006).
  • Eye Disease Case–Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol.110, 1701–1708 (1992).
  • Tamakoshi A, Yuzawa M, Matsui M, Uyama M, Fujiwara NK, Ohno Y. Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations. Br. J. Ophthalmol.81, 901–904 (1997).
  • Smith W, Assink J, Klein R et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology108, 697–704 (2001).
  • Krishnaiah S, Das T, Nirmalan PK et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh Eye Disease Study in South India. Invest. Ophthalmol. Vis. Sci.46, 4442–4449 (2005).
  • Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol.120, 1357–1363 (2002).
  • Tomany SC, Wang JJ, van Leeuwen R et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology111, 1280–1287 (2004).
  • Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am. J. Epidemiol.147, 103–110 (1998).
  • Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am. J. Epidemiol.156, 589–598 (2002).
  • Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL, III. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) Report No. 19. Ophthalmology112, 533–539 (2005).
  • Guralnik JM. The impact of vision and hearing impairments on health in old age. J. Am. Geriatr. Soc.47, 1029–1031 (1999).
  • Kelly SP, Edwards R, Elton P, Mitchell P. Age related macular degeneration: smoking entails major risk of blindness. Br. Med. J.326, 1458–1459 (2003).
  • Evans JR, Fletcher AE, Wormald RP. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br. J. Ophthalmol.89, 550–553 (2005).
  • Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, Cousins SW. Nicotine increases size and severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.45, 311–317 (2004).
  • Hawkins BS, Bird A, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol. Vis.5, 26 (1999).
  • van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. Epidemiology of age-related maculopathy: a review. Eur. J. Epidemiol.18, 845–54 (2003).
  • Lutz ME, Daoud MS, McEvoy MT, Gibson LE. Subcorneal pustular dermatosis: a clinical study of ten patients. Cutis61, 203–208 (1998).
  • Jenkins MA, Guerin MD. Quantification of serum proteins using capillary electrophoresis. Ann. Clin. Biochem.32(Pt 5), 493–497 (1995).
  • Mitchell P, Chapman S, Smith W. “Smoking is a major cause of blindness”: a new cigarette pack warning? Med. J. Aust.171, 173–174 (1999).
  • Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J. Am. Geriatr. Soc.46, 1–7 (1998).
  • Ritter LL, Klein R, Klein BE, Mares Perlman JA, Jensen SC. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am. J. Ophthalmol.120, 190–196 (1995).
  • Smith W, Mitchell P. Alcohol intake and age-related maculopathy. Am. J. Ophthalmol.122, 743–745 (1996).
  • Moss SE, Klein R, Klein BE, Jensen SC, Meuer SM. Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology105, 789–794 (1998).
  • Ajani UA, Christen WG, Manson JE et al. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann. Epidemiol.9, 172–177 (1999).
  • Cho E, Hankinson SE, Willett WC et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch. Ophthalmol.118, 681–688 (2000).
  • Taylor HR, Munoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans. Am. Ophthalmol. Soc.88, 163–173 (1990).
  • Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch. Ophthalmol.111, 514–518 (1993).
  • Delcourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A, Papoz L. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l'Age (POLA) study. Arch. Ophthalmol.119, 1463–1468 (2001).
  • Pham TQ, Wang JJ, Rochtchina E, Mitchell P. Pterygium/pinguecula and the five-year incidence of age-related maculopathy. Am. J. Ophthalmol.139, 536–537 (2005).
  • West SK, Rosenthal FS, Bressler NM et al. Exposure to sunlight and other risk factors for age-related macular degeneration [see comments]. Arch. Ophthalmol.107, 875–879 (1989).
  • Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol.119, 246–250 (2001).
  • Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol.122, 750–757 (2004).
  • Blair CJ, Ferguson J Jr. Exacerbation of senile macular degeneration following cataract extraction. Am. J. Ophthalmol.87, 77–83 (1979).
  • van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br. J. Ophthalmol.78, 441–445 (1994).
  • Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology103, 1546–1554 (1996).
  • Pollack A, Marcovich A, Bukelman A, Zalish M, Oliver M. Development of exudative age-related macular degeneration after cataract surgery. Eye11, 523–530 (1997).
  • Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J. Cataract Refract. Surg.29, 686–693 (2003).
  • Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am. J. Ophthalmol.135, 849–856 (2003).
  • Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol.120, 1551–1558 (2002).
  • Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology110, 1960–1967 (2003).
  • Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis.5, 32 (1999).
  • Seddon JM, Ajani UA, Sperduto RD et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case–Control Study Group. JAMA272, 1413–1420 (1994).
  • Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci.42, 439–446 (2001).
  • Horowitz S. Lutein update: protecting the eyes and the heart with the yellow carotenoid. Alt. Complement. Ther.6, 272–277 (2000).
  • Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.44, 2461–2465 (2003).
  • Vaicaitiene R, Luksiene DK, Paunksnis A, Cerniauskiene LR, Domarkiene S, Cimbalas A. Age-related maculopathy and consumption of fresh vegetables and fruits in urban elderly. Medicina (Kaunas.)39, 1231–1236 (2003).
  • Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch. Ophthalmol.122, 883–892 (2004).
  • Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr. Rev.57, 201–14 (1999).
  • West S, Vitale S, Hallfrisch J et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch. Ophthalmol.112, 222–227 (1994).
  • Mares-Perlman JA, Brady WE, Klein R et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch. Ophthalmol.113, 1518–1523 (1995).
  • Smith W, Mitchell P, Rochester C. Serum β carotene, α tocopherol, and age-related maculopathy: the Blue Mountains Eye Study. Am. J. Ophthalmol.124, 838–840 (1997).
  • Mares-Perlman JA, Fisher AI, Klein R et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol.153, 424–432 (2001).
  • Cardinault N, Abalain JH, Sairafi B et al. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin. Chim. Acta357, 34–42 (2005).
  • Mares-Perlman JA, Klein R, Klein BE et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch. Ophthalmol.114, 991–997 (1996).
  • Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology106, 761–767 (1999).
  • Kuzniarz M, Mitchell P, Flood VM, Wang JJ. Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic. Epidemiol.9, 283–295 (2002).
  • Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age. Arch. Ophthalmol.117, 1384–1390 (1999).
  • Delcourt C, Cristol JP, Leger CL, Descomps B, Papoz L. Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Ophthalmology106, 215–222 (1999).
  • VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am. J. Epidemiol.148, 204–214 (1998).
  • van Leeuwen R, Boekhoorn S, Vingerling JR et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA294, 3101–3107 (2005).
  • Christen WG, Ajani UA, Glynn RJ et al. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am. J. Epidemiol.149, 476–484 (1999).
  • Cho E, Stampfer MJ, Seddon JM et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann. Epidemiol.11, 328–336 (2001).
  • Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology109, 2272–2278 (2002).
  • Evans JR. Antioxidant vitamin and mineral supplements for age-related macular degeneration. Cochrane Database Syst. Rev.1–24 (2002).
  • Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.37, 1225–1235 (1996).
  • Teikari JM, Laatikainen L, Virtamo J et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol. Scand.76, 224–229 (1998).
  • Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch. Ophthalmol.119, 1417–1436 (2001).
  • Richer S, Stiles W, Statkute L et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry75, 216–230 (2004).
  • Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp. Eye Res.79, 21–27 (2004).
  • Constable IJ. Age-related macular degeneration and its possible prevention. Despite well publicised claims of the therapeutic value of dietary supplements and other new treatments, the evidence for their effectiveness is modest. Med. J. Aust.181, 471–472 (2004).
  • [No author listed]. Nutritional supplements for macular degeneration. Drug Ther. Bull.44, 9–11 (2006).
  • Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med.334, 1150–1155 (1996).
  • The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med.330, 1029–1035 (1994).
  • Virtamo J, Pietinen P, Huttunen JK et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA290, 476–485 (2003).
  • Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol.121, 1728–1737 (2003).
  • Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch. Ophthalmol.113, 743–748 (1995).
  • Cho E, Hung S, Willett WC et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr.73, 209–218 (2001).
  • Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol.6, 125–143 (1999).
  • Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye8, 269–283 (1994).
  • Rudolf M, Winkler B, Aherrahou Z, Doehring LC, Kaczmarek P, Schmidt-Erfurth U. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br. J. Ophthalmol.89, 1627–1630 (2005).
  • Duncan JL. Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration. Br. J. Ophthalmol.89, 1549–1551 (2005).
  • Nowak M, Swietochowska E, Marek B et al. Changes in lipid metabolism in women with age-related macular degeneration. Clin Exp. Med.4, 183–187 (2005).
  • Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch. Ophthalmol.118, 401–404 (2000).
  • Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch. Ophthalmol.119, 1833–1838 (2001).
  • Klein R, Klein BE, Marino EK et al. Early age-related maculopathy in the Cardiovascular Health Study. Ophthalmology110, 25–33 (2003).
  • Seddon JM, Rosner B, Sperduto RD et al. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol.119, 1191–1199 (2001).
  • Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P. Dietary fatty acids and the 5-year incidence of age related maculopathy. Arch. Ophthalmol.124, 981–986 (2006).
  • McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br. J. Ophthalmol.87, 1121–1125 (2003).
  • Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am. J. Ophthalmol.137, 615–624 (2004).
  • McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med. J. Aust.175, 340 (2001).
  • McGwin G Jr, Modjarrad K, Hall TA, Xie A, Owsley C. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch. Ophthalmol.124, 33–37 (2006).
  • Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch. Ophthalmol.121, 1151–1155 (2003).
  • Klein R, Klein BE, Jensen SC et al. Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol.119, 1354–1359 (2001).
  • van LeeuwenR, Tomany SC, Wang JJ et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology111, 1169–1175 (2004).
  • van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. Br. Med. J.326, 255–256 (2003).
  • Guymer RH, Chiu AW, Lim L, Baird PN. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Surv. Ophthalmol.50, 194–206 (2005).
  • Miyazaki M, Nakamura H, Kubo M et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. Br. J. Ophthalmol.87, 469–472 (2003).
  • Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am. J. Epidemiol.137, 190–200 (1993).
  • Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol.142, 404–409 (1995).
  • Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch. Ophthalmol.118, 351–358 (2000).
  • Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol.116, 583–587 (1998).
  • Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol.8, 237–249 (2001).
  • Paunksnis A, Cimbalas A, Cerniauskiene LR et al. Early age-related maculopathy and risk factors of cardiovascular disease in middle-aged Lithuanian urban population. Eur. J. Ophthalmol.15, 255–262 (2005).
  • Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology112, 2076–2080 (2005).
  • Nowak M, Swietochowska E, Wielkoszynski T et al. Homocysteine, vitamin B12, and folic acid in age-related macular degeneration. Eur. J. Ophthalmol.15, 764–767 (2005).
  • Seddon JM, Gensler G, Klein ML, Milton RC. Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am. J. Ophthalmol.141, 201–203 (2006).
  • Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology100, 406–414 (1993).
  • Moss SE, Klein R, Klein BE. Ankle-brachial index and the prevalence of age-related maculopathy. Am. J. Ophthalmol.140, 1159–1161 (2005).
  • Moeini HA, Masoudpour H, Ghanbari H. A study of the relation between body mass index and the incidence of age related macular degeneration. Br. J. Ophthalmol.89, 964–966 (2005).
  • Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch. Ophthalmol.119, 1259–1265 (2001).
  • Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist–hip ratio. Arch. Ophthalmol.121, 785–792 (2003).
  • Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology104, 1804–1812 (1997).
  • Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology110, 1273–1280 (2003).
  • van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest. Ophthalmol. Vis. Sci.44, 3771–3777 (2003).
  • Wang JJ, Mitchell P, Rochtchina E, Tan AG, Wong TY, Klein R. Retinal vessel wall signs and the 5 year incidence of age related maculopathy: the Blue Mountains Eye Study. Br. J. Ophthalmol.88, 104–109 (2004).
  • van Leeuwen R, Klaver CC, Vingerling JR et al. Cholesterol and age-related macular degeneration: is there a link? Am. J. Ophthalmol.137, 750–752 (2004).
  • Wu KH, Wang JJ, Rochtchina E, Foran S, Ng MK, Mitchell P. Angiotensin-converting enzyme inhibitors (ACEIs) and age-related maculopathy (ARM): cross-sectional findings from the Blue Mountains Eye Study. Acta Ophthalmol. Scand.82, 298–303 (2004).
  • Christen WG, Glynn RJ, Ajani UA et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch. Ophthalmol.119, 1143–1149 (2001).
  • Ross R. Atherosclerosis – an inflammatory disease. N. Engl. J. Med.340, 115–126 (1999).
  • Margolis TP, Lietman T, Strauss E. Infectious agents and ARMD: a connection? Am. J. Ophthalmol.138, 468–70 (2004).
  • Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.44, 3586–3592 (2003).
  • Rodriguez dC, Esparza-Gordillo J, Goicoechea dJ, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol.41, 355–367 (2004).
  • Sivaprasad S, Chong NV. The complement system and age-related macular degeneration. Eye20, 867–872 (2006).
  • Zee RY, Diehl KA, Ridker PM. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case–control study. Atherosclerosis187, 332–335 (2006).
  • Kardys I, Klaver CC, Despriet DD et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J. Am. Coll. Cardiol.47, 1568–1575 (2006).
  • Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch. Ophthalmol.121, 674–678 (2003).
  • Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ. The association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am. J. Epidemiol. (2006) (In press).
  • Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA291, 704–710 (2004).
  • Dasch B, Fuhs A, Behrens T et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch. Ophthalmol.123, 1501–1506 (2005).
  • Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol.123, 774–782 (2005).
  • Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch. Ophthalmol.121, 478–482 (2003).
  • Robman L, Mahdi O, McCarty C et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. Am. J. Epidemiol.161, 1013–1019 (2005).
  • Miller DM, Espinosa-Heidmann DG, Legra J et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am. J. Ophthalmol.138, 323–328 (2004).
  • Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch. Ophthalmol.122, 1013–1018 (2004).
  • Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br. J. Ophthalmol.87, 523–524 (2003).
  • Wang JJ, Mitchell P, Smith W, Gillies M, Billson F. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol.10, 37–48 (2003).

Website

  • Age-Related Eye Disease Study abstract abstracts.iovs.org/cgi/content/abstract/43/12/1907

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.